About Tau
The future of heart care is adaptive, precise, and patient‑centered.
At Tau Medical, we bring together technology and expertise to lead that transformation.
Who we are
A medtech venture for structural heart care.
Tau Medical is a medtech venture dedicated to advancing catheter-based therapies for structural and electrophysiological heart diseases, conditions that affect millions of people worldwide.
Our proprietary technologies are designed to address serious unmet clinical needs and reshape the future of heart valve therapy.
venture capital and government funding
cardiologists, engineers, and clinical experts
offices in Korea, USA, and India
nationalities represented across our team
Vision
To redefine the standard of care in cardiovascular medicine, with Tau’s technologies included in international clinical guidelines within five years.
Mission
To serve human life by advancing innovative, minimally invasive, and life-saving cardiovascular technologies.
Integrity
We hold ourselves to the highest standards of ethical conduct, and build trust through honesty, transparency, and accountability.
Excellence
Driven by purpose and precision, we pursue excellence in bold achievements and in the smallest meaningful details.
Innovation
We strive for creative breakthroughs that challenge convention and redefine what is possible in cardiovascular care.
Pipeline
Two programs, one approach.
- Pivot‑TRTranscatheter spacer for tricuspid regurgitation, with permanent and temporary devicesExplore Pivot‑TR
- MTR ComboOne procedure for combined mitral and tricuspid regurgitationExplore MTR Combo
Manufacturing
Designed, built, and tested in-house.
Tau Medical operates its own cleanroom and assembly line in Korea, where finished devices are built, inspected, and packaged for clinical use. Keeping production in-house lets the engineering and clinical teams move from a design change to a tested device without waiting on outside vendors.
- Finished device productionClinical-use devices are produced on site, not outsourced.
- Cleanroom assemblyDevices are assembled and packaged under controlled conditions.
- In-house prototypingDesign changes are built and evaluated on site.
- Quality systemsProduction follows documented procedures and inspection records.
Team Tau
Everyone who builds Tau.
About 50 people across R&D, production, regulatory, quality, clinical and operations, building Tau together from our offices in Korea, the U.S. and India.
Board of Directors
- Junehong Kim (Chairman)
- Sichan Sung, MD
- Andy Jang (Stassets Investment)
- Dongyoul Choi (Stonebridge Ventures)
- Vincent Jeong (Yuanta Investment)
Audit Committee
- Seong geun Kim (PNU Tech. Holdings)
Join us in transforming heart care.
We are always looking for mission-driven people to push the boundaries of innovation.
